United Therapeutics reported $315.9M in Operating Expenses for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Amarin AMRN:US USD 95.02M 62.25M
Ardelyx ARDX:US USD 32.03M 5.17M
Baxter International BAX:US USD 3.7B 2.88B
Bayer BAYN:GR EUR 10.57B 486M
Biocryst Pharmaceuticals BCRX:US USD 125.86M 32.58M
Biogen BIIB:US USD 1.84B 650.7M
Biomarin Pharmaceutical BMRN:US USD 562.04M 54.28M
Emergent Biosolutions EBS:US USD 395.8M 113.8M
Esperion Therapeutics ESPR:US USD 61.33M 728K
Gilead Sciences GILD:US USD 5.12B 917M
GlaxoSmithKline GSK:LN GBP 5.51B 1.13B
Halozyme Therapeutics HALO:US USD 106.99M 21.41M
Insmed INSM:US USD 210.77M 15.35M
Intercept Pharmaceuticals ICPT:US USD 95.24M 84.25M
Intra Cellular Therapies ITCI:US USD 135.28M 7.78M
Johnson & Johnson JNJ:US USD 19.51B 1.54B
Lexicon Pharmaceuticals LXRX:US USD 30.31M 7.17M
Moderna Inc MRNA:US USD 3.5B 1.31B
Pfizer PFE:US USD 19.12B 5.9B
Ptc Therapeutics PTCT:US USD 367.75M 82.44M
Regeneron Pharmaceuticals REGN:US USD 2.27B 555.1M
Sangamo Biosciences SGMO:US USD 82.62M 1.27M
Sarepta Therapeutics SRPT:US USD 367.84M 119.23M
Seattle Genetics SGEN:US USD 682.15M 20.95M
Teva Pharmaceutical TEVA:IT USD 4.74B 1.56B
United Therapeutics UTHR:US USD 315.9M 114.2M
Vertex Pharmaceuticals VRTX:US USD 1.27B 61.6M